Tech Company Financing Transactions

Histogenics Funding Round

On 7/24/2012, Histogenics received $49 million in Series A funding from Sofinnova Ventures, Altima Partners and BioMed Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
Proceeds will be used to complete the ongoing Phase 3 clinical program for lead product candidate NeoCart, which is currently enrolling patients. NeoCart is an autologous neocartilage tissue implant that utilizes the patient's own cells to regenerate cartilage in patients suffering from cartilage lesions in the knee. Funds will also support efforts to obtain regulatory clearance in the European Union for product candidate VeriCart, a single-step, cell-free collagen scaffold uniquely designed to be used in conjunction with the patient's own stem cells, to repair small cartilage defects frequently observed in meniscal and anterior cruciate ligament repair procedures.

Company Information

Company Status
Medical Devices & Instruments
Mailing Address
830 Winter St. 3rd Floor
Waltham, MA 02451
Email Address
Histogenics (NASDAQ: HSGX) is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.
Histogenics LinkedIn Company Profile
Social Media
Histogenics Company Twitter Account
Company News
Histogenics News
Histogenics on Facebook
Histogenics on YouTube

Management Team

Email & Social
Chief Executive Officer
Adam Gridley
  Adam Gridley LinkedIn Profile  Adam Gridley Twitter Account  Adam Gridley News  Adam Gridley on Facebook
Chief Financial Officer
Jon Lieber
  Jon Lieber LinkedIn Profile  Jon Lieber Twitter Account  Jon Lieber News  Jon Lieber on Facebook
Chief Operating Officer
Stephen Kennedy
  Stephen Kennedy LinkedIn Profile  Stephen Kennedy Twitter Account  Stephen Kennedy News  Stephen Kennedy on Facebook
VP - Bus. Development
Donald Haut
  Donald Haut LinkedIn Profile  Donald Haut Twitter Account  Donald Haut News  Donald Haut on Facebook
VP - Engineering
Caroline Dugopolski
  Caroline Dugopolski LinkedIn Profile  Caroline Dugopolski Twitter Account  Caroline Dugopolski News  Caroline Dugopolski on Facebook
VP - Finance
Harris Shuman
  Harris Shuman LinkedIn Profile  Harris Shuman Twitter Account  Harris Shuman News  Harris Shuman on Facebook
VP - Operations
Peter Hamilton
  Peter Hamilton LinkedIn Profile  Peter Hamilton Twitter Account  Peter Hamilton News  Peter Hamilton on Facebook



Browse more venture capital transactions:

Prev: 7/24/2012: Tintri venture capital transaction
Next: 7/24/2012: Tillster venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary